Compare Moderna, Inc. (MRNA) vs Okta, Inc. (OKTA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Moderna, Inc. vs Okta, Inc. — how do they compare? Moderna, Inc. trades at $59.73 (market cap $23.60B), while Okta, Inc. trades at $141.58 (market cap $25.79B). The key difference: Moderna, Inc. and Okta, Inc. are close in size by market cap, and Okta, Inc. is trading nearer its 52-week high, Moderna, Inc. nearer its low. Which is the better fit depends on your goals.
| MRNA | OKTA | |
|---|---|---|
Market Cap | $23.60B | $25.79B |
Sector | Health | Technology |
52-Week High | $81.80 | $154.62 |
52-Week Low | $22.36 | $62.93 |
Enterprise Value | $19.70B | $23.62B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Moderna, Inc.
Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.
Read more on MRNA →About Okta, Inc.
Okta is a cloud-native security company that focuses on identity and access management. The San Francisco-based firm went public in 2017 and focuses on two key client stakeholder groups: workforces and customers. Okta's workforce offerings enable a company's employees to securely access its cloud-based and on-premises resources. The firm's customer offerings allow its clients' customers to securely access the client's applications.
Read more on OKTA →
